Does orexin-A manipulation directly rescue cognitive deficits and circadian dysfunction in AD models?
PARTIALLY ADDRESSED
The authors explicitly state that studies manipulating orexin-A levels are needed to confirm its causal role in AD pathophysiology. Without direct manipulation experiments, the therapeutic potential remains speculative despite promising correlative evidence.
Gap type: open_question
Source paper: Orexin-A and Circadian Disruption in Alzheimer's Disease: Implications for Amyloid-Beta Pathology. (2025, Molecular neurobiology, PMID:41335394)
Landscape Summary:
Does orexin-A manipulation directly rescue cognitive deficits and circadian dysfunction in AD models? is a 0.87 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
Does orexin-A manipulation directly rescue cognitive deficits and circadian dysfunction in AD models? — INVOKE-2 (completed)